Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Consolidated Net Income (2016 - 2025)

Apyx Medical's Consolidated Net Income history spans 14 years, with the latest figure at -$1.2 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 82.57% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$11.1 million, up 57.31%, while the annual FY2025 figure was -$11.1 million, 57.31% up from the prior year.
  • Consolidated Net Income reached -$1.2 million in Q4 2025 per APYX's latest filing, up from -$2.0 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$1.0 million in Q2 2023 to a low of -$9.6 million in Q4 2023.
  • Average Consolidated Net Income over 5 years is -$4.7 million, with a median of -$4.7 million recorded in 2023.
  • Peak YoY movement for Consolidated Net Income: crashed 546.32% in 2024, then skyrocketed 82.57% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$2.0 million in 2021, then crashed by 201.74% to -$6.1 million in 2022, then crashed by 58.68% to -$9.6 million in 2023, then grew by 26.08% to -$7.1 million in 2024, then surged by 82.57% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Consolidated Net Income are -$1.2 million (Q4 2025), -$2.0 million (Q3 2025), and -$3.7 million (Q2 2025).